Ascension All Saints Hospital | |
3801 Spring St, Racine, Wisconsin 53405 | |
(262) 687-4011 | |
Name | Ascension All Saints Hospital |
---|---|
Type | Acute Care Hospital |
Location | 3801 Spring St, Racine, Wisconsin |
Ownership | Voluntary non-profit - Church |
Emergency Services | Yes |
Medicare ID (CCN) | 520096 |
NPI Number | 1104139021 |
Organization Name | WFHC - ALL SAINTS |
Address | 1320 Wisconsin Ave, Racine, WI 53403 |
Hospital Type | Psychiatric Hospital |
Phone Number | 262-687-4011 |
News Archive
Optimer Pharmaceuticals, Inc. announced that data from the fidaxomicin Phase 3 clinical studies will be presented at the 20th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) in Vienna, Austria.
Because of the significant benefit found in combining the targeted drug ibrutinib with standard chemotherapy for relapsed chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL), an interim analysis has closed the international HELIOS phase III clinical trial.
To understand the rules of life, we need to take the responsibility of achieving our own goals through a positive attitude. This is the primary message that the author, Alexander Sviyash, shares in How to Learn Life's Lessons and Become Life's Favorite.
In the first experiment of its kind, investigators at the Center for Cancer Nanotechnology Excellence Focused on Therapy Response (CCNE-TR), based at Stanford University, have shown that single-walled carbon nanotubes (SWCNTs) wrapped in poly(ethylene glycol), or PEG, can successfully target tumors in living animals.
› Verified 6 days ago
NPI Number | 1396158622 |
Organization Name | WHEATON FRANCISCAN HEALTHCARE-ALL SAINTS |
Doing Business As | WHEATON FRANCISCAN LIFELINE |
Address | 1320 Wisconsin Ave, Racine, WI 53403 |
Hospital Type | General Acute Care Hospital |
Phone Number | 262-687-2400 |
News Archive
Optimer Pharmaceuticals, Inc. announced that data from the fidaxomicin Phase 3 clinical studies will be presented at the 20th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) in Vienna, Austria.
Because of the significant benefit found in combining the targeted drug ibrutinib with standard chemotherapy for relapsed chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL), an interim analysis has closed the international HELIOS phase III clinical trial.
To understand the rules of life, we need to take the responsibility of achieving our own goals through a positive attitude. This is the primary message that the author, Alexander Sviyash, shares in How to Learn Life's Lessons and Become Life's Favorite.
In the first experiment of its kind, investigators at the Center for Cancer Nanotechnology Excellence Focused on Therapy Response (CCNE-TR), based at Stanford University, have shown that single-walled carbon nanotubes (SWCNTs) wrapped in poly(ethylene glycol), or PEG, can successfully target tumors in living animals.
› Verified 6 days ago
NPI Number | 1639123284 |
Organization Name | ASCENSION ALL SAINTS HOSPITAL, INC |
Doing Business As | ASCENSION ALL SAINTS HOSPITAL |
Address | 3801 Spring St, Racine, WI 53405 |
Hospital Type | General Acute Care Hospital |
Phone Number | 262-687-4011 |
News Archive
Optimer Pharmaceuticals, Inc. announced that data from the fidaxomicin Phase 3 clinical studies will be presented at the 20th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) in Vienna, Austria.
Because of the significant benefit found in combining the targeted drug ibrutinib with standard chemotherapy for relapsed chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL), an interim analysis has closed the international HELIOS phase III clinical trial.
To understand the rules of life, we need to take the responsibility of achieving our own goals through a positive attitude. This is the primary message that the author, Alexander Sviyash, shares in How to Learn Life's Lessons and Become Life's Favorite.
In the first experiment of its kind, investigators at the Center for Cancer Nanotechnology Excellence Focused on Therapy Response (CCNE-TR), based at Stanford University, have shown that single-walled carbon nanotubes (SWCNTs) wrapped in poly(ethylene glycol), or PEG, can successfully target tumors in living animals.
› Verified 6 days ago
NPI Number | 1861676439 |
Organization Name | ASCENSION ALL SAINTS HOSPITAL, INC |
Doing Business As | ASCENSION ALL SAINTS HOSPITAL |
Address | 1320 Wisconsin Ave, Racine, WI 53403 |
Hospital Type | General Acute Care Hospital |
Phone Number | 262-687-5600 |
News Archive
Optimer Pharmaceuticals, Inc. announced that data from the fidaxomicin Phase 3 clinical studies will be presented at the 20th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) in Vienna, Austria.
Because of the significant benefit found in combining the targeted drug ibrutinib with standard chemotherapy for relapsed chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL), an interim analysis has closed the international HELIOS phase III clinical trial.
To understand the rules of life, we need to take the responsibility of achieving our own goals through a positive attitude. This is the primary message that the author, Alexander Sviyash, shares in How to Learn Life's Lessons and Become Life's Favorite.
In the first experiment of its kind, investigators at the Center for Cancer Nanotechnology Excellence Focused on Therapy Response (CCNE-TR), based at Stanford University, have shown that single-walled carbon nanotubes (SWCNTs) wrapped in poly(ethylene glycol), or PEG, can successfully target tumors in living animals.
› Verified 6 days ago
Able to receive lab results electronically | Yes |
Able to track patients' lab results, tests, and referrals electronically between visits | Yes |
News Archive
Optimer Pharmaceuticals, Inc. announced that data from the fidaxomicin Phase 3 clinical studies will be presented at the 20th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) in Vienna, Austria.
Because of the significant benefit found in combining the targeted drug ibrutinib with standard chemotherapy for relapsed chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL), an interim analysis has closed the international HELIOS phase III clinical trial.
To understand the rules of life, we need to take the responsibility of achieving our own goals through a positive attitude. This is the primary message that the author, Alexander Sviyash, shares in How to Learn Life's Lessons and Become Life's Favorite.
In the first experiment of its kind, investigators at the Center for Cancer Nanotechnology Excellence Focused on Therapy Response (CCNE-TR), based at Stanford University, have shown that single-walled carbon nanotubes (SWCNTs) wrapped in poly(ethylene glycol), or PEG, can successfully target tumors in living animals.
› Verified 6 days ago
Ascension All Saints Hospital Acute Care Hospital Location: 3801 Spring St, Racine, Wisconsin 53405 Phone: (262) 687-4011 |